GUILLERMO GARCIA-MANERO to Fibroblast Growth Factor 2
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Fibroblast Growth Factor 2.
Connection Strength
0.035
-
Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis. J Clin Oncol. 2009 Oct 01; 27(28):4760-6.
Score: 0.021
-
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome. J Clin Oncol. 2004 Apr 01; 22(7):1287-92.
Score: 0.014